System results for FY23 Q2
02/15/23 01:30:pmTo ensure we are accountable to our organizational priorities, Rogers tracks key metrics and shares results on a quarterly and annual basis.
“With six months left in our current fiscal year, I am confident that we will end it on a positive note as we continue to focus on our Success Share metrics,” says John Boyd, PsyD, president and CEO. “Every single member of our team, no matter the role, contributes to our achievements, and I thank you for all you do for our patients, families, and each other.”
Clinical Effectiveness
Rogers is dedicated to enhancing our evidence-based system of care and publishing outcomes that demonstrate that our treatments are highly effective.
- Quality of Life Enjoyment and Satisfaction Questionnaire self-assessment completed at discharge of each level of treatment by all patients, measuring the degree of enjoyment and satisfaction experienced in various areas of daily functioning. Goal: 0.71 to 0.89 effect size for all patients combined. Effect size is a statistical method of quantifying the improvement someone makes from admission to discharge.
Quality of Life effect size
Q2 results = 0.91
YTD (through January) = 0.90
Patient Experience
Rogers is committed to ensuring that our patients and their families are treated with the highest degree of compassion, guidance, and professionalism throughout their treatment experience.
Measures of success
- Patient satisfaction: 84% or more weighted average of giving a good or very good likelihood of recommending Rogers on the Press Ganey survey.
Inpatient FY23 Q2 results: 1,305 surveys; 50.34% (very good) likelihood of recommending Rogers
Outpatient FY23 Q2 results: 687 surveys; 74.24% (very good) likelihood of recommending Rogers
Combined FY23 Q2 results: 1,992 surveys; 83.84% weighted average likelihood of recommending Rogers
Combined YTD (through January): 3,793 surveys; 83.05% weighted average likelihood of recommending Rogers
Healthy Culture
Rogers is committed to building a healthy culture that motivates our employees to perform at a high level and in turn provide the best environment for our patients to recover.
Measure of success
- 72% positive response on 7-question index (average of seven survey questions on satisfaction, pride, and commitment to the job and organization).
The next annual survey will take place in June. Engagement in the June 2022 survey was 72% positive responses on the index.
Financial Sustainability
Rogers is committed to responsible growth and sound fiscal management to ensure that we have the needed resources to serve our patients.
- FY23 EBIDA Target (Revenue minus expenses): $45.3 million
- Charity Care Target (Percentage of net revenue at end of fiscal year): 2.3%
EBIDA through Q2 = $8.85 million
Target through Q2 = $20.15 million
Charity Care FYTD (through January) = 1.5% I $2.4 million
